Radiology has been in the regulatory crosshairs for almost six years, ever since the DRA eliminated billions in reimbursements for imaging—and the profession can expect the trend to continue, if it doesn’t invest in research now. That’s the contention of Christoph I. Lee, MD, a UCLA Robert Wood Johnson Foundation clinical scholar, and Howard P.